These protocols are intended to provide a significant increase in growth hormone production over time while still maintaining a natural pattern of release
A groundbreaking double-blind, placebo-controlled, crossover study published in Urology (2000) examined MT-IIs effects in men with organic erectile dysfunction
The choice between tirzepatide and alternative agents should be guided by NICE recommendations (NG28 and relevant technology appraisals), considering factors such as HbA1c targets, cardiovascular risk profile, weight management goals, renal function, patient preferences, and the overall benefit-risk assessment
The cost of GLP-1 medications to treat obesity has helped drive large increases in pharmacy trends over the last three years, and despite the clear clinical benefits of this drug class, some employers and plan sponsors have chosen to discontinue coverage due to cost concerns